|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NCI Cancer Research Spending, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ranked by spending per projected 2007 death) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disease site |
2006 NCI funding ($millions) |
2007 est. new cases |
2007 est. deaths |
NCI spending per new case |
NCI spending per death |
Deaths as % of cases |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cervical |
$
83.3 |
11,150 |
3,670 |
$
7,471 |
$
22,698 |
33% |
|
|
|
|
|
|
|
|
|
|
|
|
|
AIDS* |
$
253.7 |
41,897 |
17,011 |
$
6,055 |
$
14,914 |
41% |
|
Blue = Pancreatic cancer |
|
|
|
|
|
|
|
|
|
Breast |
$
584.7 |
180,510 |
40,910 |
$
3,239 |
$
14,292 |
23% |
|
Red = Less funding than PC |
|
|
|
|
|
|
|
|
|
Melanoma |
$ 108.0 |
59,940 |
8,110 |
$
1,802 |
$
13,317 |
14% |
|
|
or more
cases/deaths |
|
|
|
|
|
|
|
|
Prostate |
$
293.2 |
218,890 |
27,050 |
$
1,339 |
$
10,839 |
12% |
|
Green = More funding than PC |
|
|
|
|
|
|
|
|
Brain |
$
130.3 |
20,500 |
12,740 |
$
6,356 |
$
10,228 |
62% |
|
|
or fewer
cases/deaths |
|
|
|
|
|
|
|
|
Leukemia |
$
223.5 |
44,240 |
21,970 |
$
5,052 |
$
10,173 |
50% |
|
Black = Overall NCI |
|
|
|
|
|
|
|
|
|
|
Total NCI Budget |
$
4,747.2 |
1,444,920 |
559,650 |
$
3,285 |
$
8,482 |
39% |
|
Sources: NCI 2006 Cancer Factbook |
|
|
|
|
|
|
|
|
Ovarian |
$
95.1 |
22,430 |
15,280 |
$
4,240 |
$
6,224 |
68% |
|
American
Cancer Society Factbook |
|
|
|
|
|
|
|
|
|
Lymphoma |
$
114.1 |
71,380 |
19,730 |
$
1,598 |
$
5,783 |
28% |
|
Centers
for Disease Control |
|
|
|
|
|
|
|
|
Colorectal |
$
244.1 |
153,760 |
52,180 |
$
1,588 |
$
4,678 |
34% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Liver |
$
62.7 |
19,160 |
16,780 |
$
3,272 |
$
3,737 |
88% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Myeloma |
$
30.3 |
19,900 |
10,790 |
$
1,523 |
$
2,808 |
54% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Endometrial/Uterine |
$
19.4 |
39,080 |
7,400 |
$
496 |
$
2,622 |
19% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Kidney |
$
33.4 |
51,190 |
12,890 |
$
652 |
$
2,591 |
25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Pancreatic |
$
74.2 |
37,170 |
33,370 |
$
1,996 |
$
2,224 |
90% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Bladder |
$
24.4 |
67,160 |
13,750 |
$
363 |
$
1,775 |
20% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Esophageal |
$
21.6 |
15,560 |
13,940 |
$
1,388 |
$
1,549 |
90% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Lung |
$
242.9 |
213,380 |
160,390 |
$
1,138 |
$
1,514 |
75% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Stomach |
$
11.5 |
21,260 |
11,210 |
$
541 |
$
1,026 |
53% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In 2006, NCI
spent $4.8 billion on cancer research (including AIDS). Of the cancers
studied, pancreatic cancer is the deadliest, with deaths representing 90
percent of new cases annually. Pancreas cancer is the 4th largest cancer
killer, but it is just the 11th most common. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Despite its grim
toll, pancreatic cancer is 14th in spending when ranked by dollars spent per
cancer death. In total spending, it ranks 11th, with just $74.2 million
invested in 2006 – less than 2 percent of NCI spending for a disease that causes 6
percent of U.S. cancer deaths (from 3 percent of cases). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For comparison,
breast cancer, which receives the most NCI research funding at more than 12 percent of the total,
produces 7 percent of cancer deaths (from 13 percent of cases). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|